STAT+: Nonprofit resurrects shelved gene therapy after startup shuts down
Last year, U.K. gene therapy startup Bloomsbury Genetic Therapies announced it was shutting down after dosing just one patient. Now, a nonprofit is resurrecting its lead program:
We haven't written up this one. STAT News has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
- STAT+: Nonprofit Bon Secours Mercy Health strikes $5.7 billion deal for surgery center chain statnews.com
- Bon Secours Mercy Health to acquire majority stake in Surgery Partners in $5.7B deal fiercehealthcare.com
- Bon Secours Affiliate to Acquire Surgery Partners in $5.7 Billion Take-Private Deal wsj.com
